Atopic Dermatitis Research Network (ADRN)
Funds centres doing clinical and translational research on eczema — chronic skin inflammation and how the skin defends itself. Four awards from $4.52 million.
Atopic dermatitis — eczema — is common, chronic and still poorly controlled in a lot of people who have it. The National Institute of Allergy and Infectious Diseases funds a network of centres to work on it.
The network's remit is to integrate clinical and translational research to improve both understanding and management of the condition, with emphasis on two things: chronic skin inflammation, …
Centres integrating clinical and translational research on atopic dermatitis to improve understanding and management of the condition, with emphasis on chronic skin inflammation and on the defence mechanisms of the skin.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up